Patents by Inventor Kathleen Matt

Kathleen Matt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230296618
    Abstract: A method of treating an inflammatory condition with a hydroxytyrosol-rich composition. Improvement is monitored as a reduction in the levels of a biochemical marker such as homocysteine or C-reactive protein. The composition may be administered in an amount and for a period sufficient to effect a drop in the level of the biochemical marker.
    Type: Application
    Filed: February 10, 2023
    Publication date: September 21, 2023
    Inventors: Kathleen Matt, Catherine M. Bitler, Roberto Crea
  • Publication number: 20200319198
    Abstract: A method of treating an inflammatory condition with a hydroxytyrosol-rich composition. Improvement is monitored as a reduction in the levels of a biochemical marker such as homocysteine or C-reactive protein. The composition may be administered in an amount and for a period sufficient to effect a drop in the level of the biochemical marker.
    Type: Application
    Filed: April 21, 2020
    Publication date: October 8, 2020
    Inventors: Kathleen Matt, Catherine M. Bitler, Roberto Crea
  • Publication number: 20110257117
    Abstract: A method of treating an inflammatory condition with a hydroxytyrosol-rich composition. Improvement is monitored as a reduction in the levels of a biochemical marker such as homocysteine or C-reactive protein. The composition may be administered in an amount and for a period sufficient to effect a drop in the level of the biochemical marker.
    Type: Application
    Filed: June 8, 2011
    Publication date: October 20, 2011
    Inventors: Kathleen Matt, Catherine M. Bitler, Roberto Crea
  • Publication number: 20080300198
    Abstract: A method of treating an inflammatory condition with a hydroxytyrosol-rich composition. Improvement is monitored as a reduction in the levels of a biochemical marker such as homocysteine or C-reactive protein. The composition may be administered in an amount and for a period sufficient to effect a drop in the level of the biochemical marker.
    Type: Application
    Filed: August 9, 2005
    Publication date: December 4, 2008
    Inventors: Kathleen Matt, Catherine M. Bitler